ROGER STOLL, the former chief executive of Ohmeda, the healthcare company sold by industrial gases group BOC for pounds 604m earlier this year, received a pounds 1.8m payoff when he resigned in April, according to company accounts.
The payment consisted of two years' salary, plus a bonus of pounds 1.1m connected to the disposal of Ohmeda to a consortium comprising the Finnish company Instrumentarium and two US healthcare groups, Becton Dickinson and Baxter International.
Mr Stoll also exercised share options worth a further pounds 197,000.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments